Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

NCT05537584 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT05537584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05537584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
Lead sponsor
Mclean Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2022
Completion date
August 26, 2025
Enrollment
133 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder